Skip to main content
. 2022 Feb 7;15(3):395–404. doi: 10.1159/000522082

Table 1.

Baseline characteristics of the study population

Parameters 104HD (n = 34) 104LD (n = 33) Placebo (n = 33
Age 43.2±13.0 46.8±13.2 46.2±14.0
Gender, n (%)
 Male 11 (32.4) 14 (42.4) 9 (27.3)
 Female 23 (67.6) 19 (57.6) 24 (72.7)
Systolic blood pressure, mm Hg 128.4±6.9 128.0±10.1 127.2±10.2
Diastolic blood pressure, mm Hg 80.3±5.7 79.3±7.1 79.5±5.6
Pulse, bpm 73.3±5.9 72.2±8.0 70.4±8.8
Body weight, kg 85.31±12.56 89.47±14.28 87.42±12.92
Height, cm 170.1±9.3 171.7±8.9 169.6±10.5
BMI, kg/m2 29.39±2.69 30.17±2.84 30.28±2.07
Body fat mass, kg 28.97±8.21 30.91±7.20 30.62±6.56
Fat free mass, kg 56.05±10.64 58.56±12.57 55.56±11.53
Waist circumference, cm 106.2±10.8 108.6±10.0 107.9±8.9
Hip circumference, cm 108.0±8.5 112.2±8.4 110.5±5.8
Energy intake, kcal 1,761±281 1,832±319 1,771±322

Data are presented as mean ± SD or n (%) of participants for full analysis set population. No significant differences between groups for all parameters.